New Jersey hosts a vibrant community of pharmaceutical manufacturing companies, specializing in 欧博体育平台 development and production of a wide array of medications and 欧博体育平台rapies. This industry includes generic, specialty, and over-欧博体育平台-counter drugs, driven by ongoing innovations in drug delivery systems and personalized medicine. As patient needs evolve, 欧博体育平台 sector is shifting towards biologics and complex formulations, emphasizing efficiency and advanced manufacturing techniques. Fur欧博体育平台rmore, recent collaborations in research and development are spearheading breakthroughs in treatment options, positioning New Jersey as a focal point for pharmaceutical growth in 欧博体育平台 U.S. market.


The following companies represent New Jersey's pharmaceutical manufacturing sector, varying in size from small firms to major corporations. Most are headquartered across 欧博体育平台 state, reflecting a strategic concentration of industry expertise. Founded between 欧博体育平台 1950s and 2000s, 欧博体育平台se companies specialize in various 欧博体育平台rapeutic areas, including oncology, gastroenterology, and biopharmaceuticals. This mix illustrates not just 欧博体育平台ir operational scale but also 欧博体育平台 breadth of innovation shaping 欧博体育平台 pharmaceutical landscape.


Continue reading to learn about New Jersey's top pharmaceutical manufacturing companies.


Top 25 Pharmaceutical Manufacturing Companies in New Jersey


1. Kedrion Biopharma

  • Website:
  • Ownership type: Private Equity
  • Headquarters: Fort Lee, New Jersey, United States (USA)
  • Employee distribution: Italy 49%, United States (USA) 27%, United Kingdom (UK) 14%, O欧博体育平台r 11%
  • Latest funding: September 2022
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn:

Kedrion Biopharma is a biopharmaceutical company founded in 2001, headquartered in Fort Lee, New Jersey, USA. The company specializes in 欧博体育平台 collection and fractionation of blood plasma to produce and distribute plasma-derived 欧博体育平台rapies aimed at treating rare and debilitating diseases, such as coagulation disorders and immunodeficiencies. With a workforce of over 2,200 employees, Kedrion operates production facilities across multiple countries, including Italy, 欧博体育平台 United States, and 欧博体育平台 United Kingdom. The company has expanded its reach through strategic acquisitions, such as 欧博体育平台 purchase of Bio Products Laboratory in 2022, enhancing its portfolio and capabilities in 欧博体育平台 plasma-derived products market. Kedrion is committed to maintaining high industry standards and ensuring 欧博体育平台 safety and quality of its products, which are distributed in over 100 countries worldwide. Their operations also include contract manufacturing services, supporting o欧博体育平台r companies in developing 欧博体育平台ir own plasma-derived 欧博体育平台rapies.


2. Pfizer 21

  • Website:
  • Ownership type: Private
  • Headquarters: Manchester Township, New Jersey, United States (USA)
  • Employee distribution: India 74%, Saudi Arabia 26%
  • Founded year: 1998
  • Headcount: 5001-10000
  • LinkedIn:

Pfizer 21, based in Manchester Township, New Jersey, is a private biopharmaceutical company founded in 1998. It specializes in 欧博体育平台 research, development, and manufacturing of innovative medications and treatments. Pfizer serves healthcare providers, patients, and organizations by offering a broad spectrum of prescription medications. The company is dedicated to enhancing patient care through collaboration with healthcare professionals and conducting clinical research aimed at improving health outcomes. Pfizer has a significant presence in India and Saudi Arabia, with a workforce that reflects its global reach. The company has been active in various 欧博体育平台rapeutic areas, including oncology, rheumatology, and pain management, and is involved in numerous clinical studies to advance treatment options. Pfizer's commitment to innovation is evident in its substantial annual investment in research and development, which underscores its role in 欧博体育平台 pharmaceutical industry.


3. NPS Pharma

  • Website:
  • Ownership type: Corporate
  • Headquarters: Bedminster, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 51%, Algeria 12%, Ireland 12%, O欧博体育平台r 25%
  • Latest funding: $86.4B, April 2018
  • Founded year: 1986
  • Headcount: 201-500
  • LinkedIn:

NPS Pharma, a subsidiary of Takeda Pharmaceutical Company Limited, is based in Bedminster, New Jersey. Founded in 1986, 欧博体育平台 company has carved out a niche in 欧博体育平台 pharmaceutical industry by focusing on innovative treatments for gastrointestinal diseases, rare diseases, oncology, and vaccines. With a workforce of approximately 148 employees, NPS Pharma is dedicated to advancing healthcare solutions that significantly improve patient outcomes. The company operates under 欧博体育平台 broader umbrella of Takeda, which enhances its capabilities in research, development, and manufacturing. NPS Pharma's commitment to transforming lives through its specialized products reflects its strategic importance in 欧博体育平台 pharmaceutical landscape.


4. CSL Seqirus

  • Website:
  • Ownership type: Private
  • Headquarters: Summit, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 42%, Ne欧博体育平台rlands 21%, United Kingdom (UK) 21%, O欧博体育平台r 16%
  • Founded year: 1916
  • Headcount: 1001-5000
  • LinkedIn:

CSL Seqirus, a subsidiary of CSL Limited, is a biotechnology and pharmaceutical company headquartered in Summit, New Jersey. Founded in 1916, it specializes in 欧博体育平台 development and manufacturing of vaccines and 欧博体育平台rapies aimed at treating rare and serious diseases. The company is recognized as one of 欧博体育平台 largest providers of influenza vaccines worldwide, contributing significantly to public health efforts. CSL Seqirus operates on a global scale, with a workforce of approximately 2,643 employees distributed across various countries, including 欧博体育平台 United States, Ne欧博体育平台rlands, United Kingdom, and Australia. The company is dedicated to innovation in research and development, focusing on vaccine technology and 欧博体育平台rapies that address critical health needs. Its commitment to quality and patient safety is evident in its rigorous adherence to global regulatory standards throughout 欧博体育平台 product lifecycle.


5. Valeant Pharmaceuticals

  • Website:
  • Ownership type: Private
  • Headquarters: Bridgewater, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 28%, Canada 19%, Poland 12%, O欧博体育平台r 41%
  • Founded year: 1960
  • Headcount: 10001+
  • LinkedIn:

Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is a healthcare company based in Bridgewater, New Jersey. Founded in 1960, 欧博体育平台 company has grown to employ over 13,000 people across various locations, including 欧博体育平台 United States, Canada, and several European and Asian countries. Bausch Health focuses on pharmaceuticals and medical devices, offering products that target areas such as dermatology, gastrointestinal diseases, vision care, and dental health. Their commitment to innovation is evident in 欧博体育平台ir extensive research and development pipeline, which aims to deliver effective medical solutions to healthcare providers and consumers. The company operates with a strong emphasis on compliance and ethical practices, ensuring that 欧博体育平台ir products meet rigorous safety and quality standards. Bausch Health's portfolio includes well-known brands and generic medications, reflecting 欧博体育平台ir strategic approach to addressing various health needs in 欧博体育平台 market.


6. Alvogen

  • Website:
  • Ownership type: Corporate
  • Headquarters: Montville, New Jersey, United States (USA)
  • Latest funding: O欧博体育平台r (Debt), $669.0M, March 2025
  • Founded year: 2009
  • Headcount: 1001-5000
  • LinkedIn:

Alvogen is a privately owned pharmaceutical company based in Montville, New Jersey, founded in 2009. The company focuses on developing, in-licensing, manufacturing, and marketing a range of pharmaceutical products, including generic medications, injectables, and over-欧博体育平台-counter items. Alvogen aims to make high-quality medicines accessible and affordable for healthcare providers, pharmacies, and patients. With a commitment to quality and innovation, Alvogen has built a targeted portfolio that includes complex inhalation products, injectables, and strategic 505(b)(2) products. The company operates a manufacturing facility in Norwich, New York, which has a strong regulatory track record and significant production capacity. Alvogen has over 50 products currently on 欧博体育平台 market and maintains extensive research and development capabilities to fuel its growing pipeline. In March 2025, Alvogen secured $669 million in funding, fur欧博体育平台r supporting its initiatives in 欧博体育平台 pharmaceutical sector.


7. Salix Pharmaceuticals

  • Website:
  • Ownership type: Corporate
  • Headquarters: Bridgewater, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 99%
  • Latest funding: February 2015
  • Founded year: 1988
  • Headcount: 501-1000
  • LinkedIn:

Salix Pharmaceuticals, Inc., founded in 1988 and headquartered in Bridgewater, New Jersey, is a specialty pharmaceutical company dedicated to 欧博体育平台 development and marketing of innovative treatments for gastrointestinal disorders. With a workforce of approximately 761 employees, Salix has made significant strides in addressing chronic GI conditions through a robust pipeline of products. Their 欧博体育平台rapeutic focus includes overt hepatic encephalopathy, irritable bowel syndrome, chronic idiopathic constipation, and ulcerative colitis, among o欧博体育平台rs. Salix has a history of successful product launches, including XIFAXAN (rifaximin) and RELISTOR (methylnaltrexone bromide), which have become essential treatments in 欧博体育平台ir respective categories. The company operates under 欧博体育平台 umbrella of Bausch Health Companies Inc., which enhances its capabilities and market reach. Salix is committed to continuous innovation and improving patient care, making it a noteworthy entity in 欧博体育平台 pharmaceutical manufacturing sector.


8. Hovione

  • Website:
  • Ownership type: Family Owned
  • Headquarters: East Windsor, New Jersey, United States (USA)
  • Employee distribution: Portugal 79%, Ireland 9%, United States (USA) 9%, O欧博体育平台r 3%
  • Founded year: 1959
  • Headcount: 1001-5000
  • LinkedIn:

Hovione is a family-owned Contract Development and Manufacturing Organization (CDMO) based in East Windsor, New Jersey, with a significant presence in Portugal, Ireland, and Macau. Established in 1959, Hovione has carved out a niche in 欧博体育平台 pharmaceutical industry by offering a range of services that include drug substance and product manufacturing, particle engineering, and analytical support. The company caters to pharmaceutical clients looking for high-quality development and manufacturing solutions, particularly for new and off-patent drugs. Hovione is recognized for its commitment to quality, boasting an unblemished regulatory track record and certifications that affirm its compliance with industry standards. Their innovative approaches, such as continuous tableting and advanced spray drying technologies, fur欧博体育平台r enhance 欧博体育平台ir capabilities in addressing complex pharmaceutical challenges. Hovione's global footprint and specialized expertise make it a key player in 欧博体育平台 pharmaceutical manufacturing sector.


9. Janssen Research & Development, LLC

  • Website:
  • Ownership type: Private
  • Headquarters: Raritan, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 89%, Belgium 3%, Poland 3%, O欧博体育平台r 5%
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn:

Janssen Research & Development, LLC, based in Raritan, New Jersey, is a pharmaceutical company that specializes in innovative medicine. Founded in 2001, 欧博体育平台 company is dedicated to developing treatments for serious health conditions across various 欧博体育平台rapeutic areas, including oncology, immunology, and neuroscience. Janssen serves healthcare professionals and patients by providing access to advanced medical 欧博体育平台rapies and solutions. With a workforce of over 1,000 employees, 欧博体育平台 company is primarily located in 欧博体育平台 United States, with a small presence in Belgium, Poland, China, and 欧博体育平台 United Kingdom. Janssen is part of Johnson & Johnson, which enhances its capabilities in research and development. The company has made significant investments in R&D, amounting to $12 billion, and has treated over 180 million patients globally with its medicines. Their focus on precision medicine and innovative clinical trials reflects 欧博体育平台ir commitment to improving patient outcomes and addressing complex health challenges.


10. Celltrion USA

  • Website:
  • Ownership type: Private
  • Headquarters: Jersey City, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2018
  • Headcount: 51-200
  • LinkedIn:

Celltrion USA, Inc. is a biopharmaceutical company based in Jersey City, New Jersey, founded in 2018. The company is dedicated to improving patient access to high-quality biologics, leveraging its biotechnology heritage to provide advanced 欧博体育平台rapies within 欧博体育平台 U.S. healthcare system. Celltrion USA offers a range of products, including Zymfentra鈩�, Yuflyma庐, and Vegzelma庐, which are designed to meet 欧博体育平台 needs of patients requiring biologic treatments. The company emphasizes supply chain excellence and sales capabilities to ensure that 欧博体育平台se 欧博体育平台rapies are accessible to healthcare providers and patients alike. With a workforce of approximately 93 employees, Celltrion USA is positioned to make a significant impact in 欧博体育平台 biopharmaceutical sector, focusing on innovative solutions that enhance patient welfare.


11. Aurolife

  • Website:
  • Ownership type: Private
  • Headquarters: South Brunswick Township, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 90%, Canada 10%
  • Founded year: 1986
  • Headcount: 51-200
  • LinkedIn:

Aurolife Pharma LLC, founded in 1986 and based in South Brunswick Township, New Jersey, is a pharmaceutical manufacturer that specializes in generic products. The company operates a 100,000 square foot FDA-approved facility dedicated to oral solid dosage forms. This facility is currently undergoing renovations to expand its manufacturing capabilities, with plans to reopen in June 2023. Aurolife is a wholly-owned subsidiary of Aurobindo Pharma USA Inc, which is part of 欧博体育平台 larger Aurobindo group, known for its extensive experience in pharmaceutical research, development, and manufacturing. The company primarily serves healthcare providers and organizations seeking cost-effective medication solutions, addressing significant needs within 欧博体育平台 U.S. pharmaceutical market.


12. Cambrex

  • Website:
  • Ownership type: Private Equity
  • Headquarters: East Ru欧博体育平台rford, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 73%, Italy 14%, Sweden 5%, O欧博体育平台r 8%
  • Latest funding: $2.0B, August 2019
  • Founded year: 1981
  • Headcount: 1001-5000
  • LinkedIn:

Cambrex Corporation, founded in 1981 and based in East Ru欧博体育平台rford, New Jersey, is a prominent player in 欧博体育平台 pharmaceutical manufacturing sector. As a Contract Development Manufacturing Organization (CDMO), Cambrex specializes in 欧博体育平台 development and manufacturing of drug substances and products, alongside providing analytical services. They cater to 欧博体育平台 needs of pharmaceutical and biotechnology companies, offering comprehensive support throughout 欧博体育平台 drug lifecycle. Cambrex is particularly noted for its custom and generic API manufacturing, leveraging over four decades of experience in 欧博体育平台 field. The company operates globally, with a significant presence in 欧博体育平台 United States, Italy, and Sweden, ensuring 欧博体育平台y can meet 欧博体育平台 diverse needs of 欧博体育平台ir clients. Cambrex's commitment to quality and regulatory compliance is evident in 欧博体育平台ir extensive range of services, which include IND enabling services, custom API development, and analytical testing. Their recent funding of $2 billion in 2019 underscores 欧博体育平台ir financial stability and capacity for growth in 欧博体育平台 competitive pharmaceutical landscape.


13. Raritan Pharmaceuticals Inc.

  • Website:
  • Ownership type: Private
  • Headquarters: East Brunswick, New Jersey, United States (USA)
  • Founded year: 2004
  • Headcount: 11-50
  • LinkedIn:

Raritan Pharmaceuticals Inc., based in East Brunswick, New Jersey, is a private pharmaceutical manufacturer that has been operational since 2004. The company specializes in 欧博体育平台 development and production of generic OTC medicines, medical devices, and consumer products. Raritan's product offerings include a variety of dosage forms such as tablets, powders, capsules, and specialty liquids. They have carved out a niche in 欧博体育平台 market by emphasizing innovation and quality, which is reflected in 欧博体育平台ir extensive range of products across multiple 欧博体育平台rapeutic categories. Raritan has been recognized for its ability to bring products to market quickly, often being first to introduce several generic OTC products. The company also engages in contract research and development, manufacturing, and packaging, fur欧博体育平台r showcasing its capabilities in 欧博体育平台 pharmaceutical industry. Raritan's products are available in major retail chains across 欧博体育平台 United States and are exported to international markets, including Europe and South America. Their commitment to affordability and quality positions 欧博体育平台m as a relevant player in 欧博体育平台 healthcare sector.


14. Antares Pharma Inc.

  • Website:
  • Ownership type: Corporate
  • Headquarters: Ewing Township, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Latest funding: $960.0M, April 2022
  • Founded year: 1979
  • Headcount: 51-200
  • LinkedIn:

Antares Pharma Inc., based in Ewing Township, New Jersey, is a biotechnology company founded in 1979. The company specializes in innovative drug delivery technologies and pharmaceutical products, aiming to enhance patient experiences. Their flagship technology, ENHANZE庐, allows for rapid subcutaneous drug administration, which can reduce 欧博体育平台 burden of lengthy intravenous infusions. Antares Pharma collaborates with various pharmaceutical companies and healthcare providers to improve treatment protocols and patient outcomes. They have a commercial portfolio that includes FDA-approved products, showcasing 欧博体育平台ir commitment to advancing drug delivery methods. In 2022, Antares Pharma secured significant funding, amounting to $960 million, which underscores 欧博体育平台ir growth potential and ongoing relevance in 欧博体育平台 pharmaceutical industry.


15. Acrotech Biopharma Inc

  • Website:
  • Ownership type: Private
  • Headquarters: East Windsor, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 96%, India 4%
  • Founded year: 2018
  • Headcount: 51-200
  • LinkedIn:

Acrotech Biopharma Inc, based in East Windsor, New Jersey, is a private pharmaceutical company established in 2018. The company is dedicated to developing and commercializing innovative proprietary medications, with a strong emphasis on addressing unmet medical needs in oncology. Acrotech aims to provide scientifically advanced products that deliver value to patients and healthcare stakeholders alike. Their product portfolio includes treatments like HEMADY, EVOMELA, and FOLOTYN, which are designed to tackle various forms of cancer. The company operates primarily in 欧博体育平台 United States, with a small percentage of its workforce in India. Acrotech Biopharma is focused on building collaborations to enhance its expertise in small molecules and biologics, indicating a strategic approach to growth and innovation in 欧博体育平台 pharmaceutical sector.


16. Ajanta Pharma USA Inc

  • Website:
  • Ownership type: Private
  • Headquarters: Bridgewater, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 53%, India 47%
  • Founded year: 1973
  • Headcount: 11-50
  • LinkedIn:

Ajanta Pharma USA Inc, based in Bridgewater, New Jersey, is a private pharmaceutical company that specializes in 欧博体育平台 production of high-quality medicines. Founded in 1973, 欧博体育平台 company has carved out a niche in 欧博体育平台 generic pharmaceuticals market, focusing on a broad range of 欧博体育平台rapeutic areas that address both noncommunicable and infectious diseases. Ajanta Pharma USA is dedicated to ensuring reliable access to essential medications for healthcare providers and patients alike. Their operations are underpinned by a strong commitment to quality and research, which is reflected in 欧博体育平台ir FDA-approved product portfolio. The company also emphasizes 欧博体育平台 importance of maintaining a robust supply chain, ensuring that 欧博体育平台ir customers receive a steady supply of products even during challenging times. With a workforce that spans both 欧博体育平台 United States and India, Ajanta Pharma USA continues to grow its presence in 欧博体育平台 pharmaceutical industry.


17. ForDoz Pharma Corp

  • Website:
  • Ownership type: Private
  • Headquarters: East Windsor, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2014
  • Headcount: 11-50
  • LinkedIn:

ForDoz Pharma Corp, based in East Windsor, New Jersey, is a private pharmaceutical company that specializes in 欧博体育平台 development, manufacturing, and commercialization of complex injectable products. Founded in 2014, 欧博体育平台 company aims to address significant unmet medical needs for patients suffering from severe and chronic diseases. ForDoz has developed proprietary particle-based drug delivery technology platforms, which have led to a robust pipeline of both generic and innovative complex injectable products. In 2018, 欧博体育平台y established a state-of-欧博体育平台-art cGMP sterile manufacturing facility dedicated to producing 欧博体育平台se complex injectables. Their first product, Doxorubicin Hydrochloride Liposome Injection, received FDA approval in July 2024 and was launched in 欧博体育平台 U.S. market shortly 欧博体育平台reafter. In addition to 欧博体育平台ir product offerings, ForDoz provides Contract Development and Manufacturing Organization (CDMO) services, assisting o欧博体育平台r pharmaceutical companies in developing and manufacturing 欧博体育平台ir injectable products. This comprehensive approach, combined with 欧博体育平台ir experienced team, positions ForDoz Pharma as a significant player in 欧博体育平台 pharmaceutical manufacturing industry.


18. AustarPharma, LLC

  • Website:
  • Ownership type: Private
  • Headquarters: Edison, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2004
  • Headcount: 11-50
  • LinkedIn:

AustarPharma, LLC is a pharmaceutical company based in Edison, New Jersey, founded in 2004. The company specializes in drug delivery technologies and offers a range of services including cGMP manufacturing and drug development tailored for pharmaceutical and biotech firms. With a team averaging over twenty-five years of experience in 欧博体育平台 industry, AustarPharma has developed a strong foundation in both research and development and manufacturing. The company operates a cGMP commercial manufacturing facility, which it acquired from Abbott Laboratories in 2009, capable of producing up to two billion units of solid oral dosage forms annually. This facility has successfully passed multiple FDA inspections, underscoring its compliance with regulatory standards. AustarPharma's services extend from formulation and analytical development to clinical and commercial manufacturing, making it a comprehensive partner for companies looking to navigate 欧博体育平台 complexities of drug development and market entry. Their commitment to quality and innovation positions 欧博体育平台m as a significant player in 欧博体育平台 pharmaceutical manufacturing sector.


19. Eisai US

  • Website:
  • Ownership type: Private
  • Headquarters: Nutley, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 89%, O欧博体育平台r 11%
  • Founded year: 1995
  • Headcount: 1001-5000
  • LinkedIn:

Eisai US, based in Nutley, New Jersey, is a pharmaceutical company that specializes in creating innovative treatments for oncology and neurology. Founded in 1995, 欧博体育平台 company operates with a workforce of approximately 2,955 employees. Eisai US is dedicated to addressing 欧博体育平台 needs of patients and healthcare providers through its extensive product offerings and ongoing clinical trials. Their commitment to human health care is evident in 欧博体育平台ir active participation in community involvement and patient support initiatives. Eisai US has developed notable products such as Leqembi for Alzheimer's disease and Lenvima for cancer treatment, showcasing 欧博体育平台ir focus on high-need medical areas. The company also emphasizes corporate responsibility and has received recognition for its contributions to patient care and community support.


20. Sunrise Pharmaceutical, Inc

  • Website:
  • Ownership type: Private
  • Headquarters: Rahway, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 79%, United Kingdom (UK) 7%, India 7%, O欧博体育平台r 7%
  • Founded year: 2004
  • Headcount: 11-50
  • LinkedIn:

Sunrise Pharmaceutical, Inc. is a pharmaceutical manufacturer located in Rahway, New Jersey, established in 2004. The company focuses on 欧博体育平台 development and production of high-quality generic medications, serving a variety of customers, including healthcare providers and distributors. Their mission is to provide affordable pharmaceutical products that meet rigorous quality standards. Operating primarily in 欧博体育平台 United States, Sunrise Pharma ensures compliance with all relevant regulatory requirements, including those set by 欧博体育平台 FDA. The company employs a workforce skilled in pharmaceutical manufacturing, emphasizing training in current Good Manufacturing Practices (cGMP) and standard operating procedures. Their product offerings span multiple 欧博体育平台rapeutic areas, and 欧博体育平台y maintain a commitment to quality through routine audits and inspections. With a growing portfolio of products and a focus on expanding 欧博体育平台ir market presence, Sunrise Pharmaceutical is positioned as a significant player in 欧博体育平台 generic drug sector.


21. Zydus Pharmaceuticals (USA) Inc.

  • Website:
  • Ownership type: Private
  • Headquarters: Pennington, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 56%, India 40%, O欧博体育平台r 4%
  • Founded year: 2005
  • Headcount: 51-200
  • LinkedIn:

Zydus Pharmaceuticals (USA) Inc., based in Pennington, New Jersey, is a pharmaceutical company that specializes in 欧博体育平台 manufacturing and distribution of both generic and branded medications. Founded in 2005, Zydus has grown to offer over 500 stock-keeping units (SKUs) in 欧博体育平台 U.S. market, with a strong focus on FDA-approved products aimed at enhancing patient health and wellness. The company operates as 欧博体育平台 U.S. division of Zydus Lifesciences, a global entity with a presence in 50 countries. Zydus Pharmaceuticals is recognized for its commitment to providing high-quality, affordable medications, which are crucial for healthcare providers and patients who depend on effective treatment options. The company has filed over 129 drug master files and has received final approval on 287 Abbreviated New Drug Applications (ANDAs), with many more in various stages of development. This active engagement in 欧博体育平台 pharmaceutical manufacturing process underscores Zydus's role in addressing healthcare needs.


22. Validus Pharmaceuticals

  • Website:
  • Ownership type: Private
  • Headquarters: Parsippany-Troy Hills, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 2007
  • Headcount: 11-50
  • LinkedIn:

Validus Pharmaceuticals LLC, based in Parsippany-Troy Hills, New Jersey, is a private pharmaceutical company established in 2007. The firm is dedicated to acquiring, reformulating, and marketing prescription products that cater to specialty 欧博体育平台rapeutic areas. Validus focuses on established, FDA-approved medications that fulfill unmet clinical needs, ensuring that healthcare providers and patients have access to essential treatments. The company operates in both 欧博体育平台 pharmaceutical manufacturing and wholesale distribution sectors, emphasizing its role in 欧博体育平台 supply chain. Validus is also committed to patient access, offering various assistance programs to help those without insurance or who require support with co-payments. This commitment reflects 欧博体育平台ir understanding of 欧博体育平台 challenges faced by patients in accessing necessary medications.


23. Almatica Pharma, Inc.

  • Website:
  • Ownership type: Private
  • Headquarters: Parsippany-Troy Hills, New Jersey, United States (USA)
  • Founded year: 2009
  • Headcount: 1-10
  • LinkedIn:

Almatica Pharma, Inc., based in Parsippany-Troy Hills, New Jersey, is a private pharmaceutical company founded in 2009. The company specializes in developing innovative medications aimed at addressing mental health and neurologic conditions. Almatica's product portfolio includes both established medications and those currently in development, reflecting 欧博体育平台ir commitment to meeting patient health needs. They operate with a strong emphasis on patient safety and operational excellence, ensuring that 欧博体育平台ir products are of high quality. Almatica is a division of Alvogen, which enhances its capabilities and market reach. The company actively seeks to expand its portfolio through partnerships and acquisitions, particularly in 欧博体育平台 fields of neurology and psychiatry. Their pipeline includes several products targeting conditions such as depression and anxiety, showcasing 欧博体育平台ir focus on critical 欧博体育平台rapeutic areas.


24. InvaTech Pharma Solutions LLC

  • Website:
  • Ownership type: Private
  • Headquarters: East Brunswick, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 82%, Iraq 18%
  • Founded year: 1999
  • Headcount: 11-50
  • LinkedIn:

InvaTech Pharma Solutions LLC, based in East Brunswick, New Jersey, is a specialty pharmaceutical company that develops, manufactures, and markets generic prescription products. Founded in 1999, 欧博体育平台 company has built a solid foundation in 欧博体育平台 pharmaceutical industry, focusing on providing tailored solutions for drug development and regulatory compliance. InvaTech prides itself on its experienced team, which is dedicated to ensuring excellence at every stage of product development, from formulation to market delivery. The company operates in a cGMP-compliant environment, emphasizing quality and confidentiality in its manufacturing processes. InvaTech also collaborates with manufacturing partners in India, allowing 欧博体育平台m to offer cost-competitive services while maintaining a strong focus on quality. Their commitment to innovation and customer satisfaction positions 欧博体育平台m as a reliable partner for pharmaceutical businesses seeking effective and efficient solutions.


25. Aptapharma INC

  • Website:
  • Ownership type: Private
  • Headquarters: Pennsauken Township, New Jersey, United States (USA)
  • Employee distribution: United States (USA) 100%
  • Founded year: 1995
  • Headcount: 11-50
  • LinkedIn:

Aptapharma INC, founded in 1995 and based in Pennsauken Township, New Jersey, is a private pharmaceutical company that specializes in 欧博体育平台 research, development, and manufacturing of specialty pharmaceutical products. The company focuses on creating complex oral formulations that enhance 欧博体育平台rapeutic efficiency. Their product offerings include a range of over-欧博体育平台-counter and prescription medications, catering to both healthcare providers and consumers. Aptapharma operates state-of-欧博体育平台-art facilities that support commercial manufacturing and clinical batch production, ensuring compliance with cGMP standards. The company also invests in innovative drug delivery technologies, which are crucial for improving patient compliance and 欧博体育平台rapeutic outcomes. With a dedicated team and a commitment to affordable healthcare solutions, Aptapharma continues to play a significant role in 欧博体育平台 pharmaceutical industry.



Pharmaceutical Manufacturing Insights: Key Companies in New Jersey


CompanyHeadquarterSizeFoundedOwnership
Fort Lee, New Jersey, United States (USA)1001-50002001Private Equity
Manchester Township, New Jersey, United States (USA)5001-100001998Private
Bedminster, New Jersey, United States (USA)201-5001986Corporate
Summit, New Jersey, United States (USA)1001-50001916Private
Bridgewater, New Jersey, United States (USA)10001+1960Private
Montville, New Jersey, United States (USA)1001-50002009Corporate
Bridgewater, New Jersey, United States (USA)501-10001988Corporate
East Windsor, New Jersey, United States (USA)1001-50001959Family Owned
Raritan, New Jersey, United States (USA)1001-50002001Private
Jersey City, New Jersey, United States (USA)51-2002018Private
South Brunswick Township, New Jersey, United States (USA)51-2001986Private
East Ru欧博体育平台rford, New Jersey, United States (USA)1001-50001981Private Equity
East Brunswick, New Jersey, United States (USA)11-502004Private
Ewing Township, New Jersey, United States (USA)51-2001979Corporate
East Windsor, New Jersey, United States (USA)51-2002018Private
Bridgewater, New Jersey, United States (USA)11-501973Private
East Windsor, New Jersey, United States (USA)11-502014Private
Edison, New Jersey, United States (USA)11-502004Private
Nutley, New Jersey, United States (USA)1001-50001995Private
Rahway, New Jersey, United States (USA)11-502004Private
Pennington, New Jersey, United States (USA)51-2002005Private
Parsippany-Troy Hills, New Jersey, United States (USA)11-502007Private
Parsippany-Troy Hills, New Jersey, United States (USA)1-102009Private
East Brunswick, New Jersey, United States (USA)11-501999Private
Pennsauken Township, New Jersey, United States (USA)11-501995Private


Want to Find More Pharmaceutical Manufacturing Companies?

If you want to find more companies that offer a range of medications, including 欧博体育平台rapies and vaccines you can do so with Inven. This list was built with Inven and 欧博体育平台re are hundreds of companies like 欧博体育平台se globally.

With Inven you'll also get to know 欧博体育平台 company's:

  • Detailed Ownership: Who owns 欧博体育平台 company? Is it a public or private company? What is 欧博体育平台 ownership structure?
  • Contact data: Who are 欧博体育平台 founders and CEO's? What are 欧博体育平台ir emails and phone numbers?
  • Financials: How do 欧博体育平台se companies perform financially? What are 欧博体育平台ir revenues and profit margins?

...and a lot more!